Trial NCT00889187

View at ClinicalTrials.gov 
Org. Study IDs: 08-375

Last trial update was posted on 2018-05-11

MeSH Interventions

Capecitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Excess toxicity was identified intraoperatively

Limitations And Caveats

The study did not proceed to phase II due to unexpected intraoperative complications experienced by patients enrolled on phase I.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID